HEADER TRANSPORT PROTEIN 06-OCT-15 5E4O TITLE HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH (Z)-((3,4-DICHLORO-PHENYL)- TITLE 2 METHYLENEAMINOOXY)-ACETIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSTHYRETIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 30-146; COMPND 5 SYNONYM: ATTR,PREALBUMIN,TBPA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS FLUORENONE BASED FIBRILLOGENESIS INHIBITOR, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.CICCONE,M.SAVKO,S.NENCETTI,A.ROSSELLO,E.ORLANDINI,E.A.STURA REVDAT 3 07-DEC-16 5E4O 1 JRNL REVDAT 2 27-APR-16 5E4O 1 JRNL REVDAT 1 23-MAR-16 5E4O 0 JRNL AUTH L.CICCONE,S.NENCETTI,A.ROSSELLO,E.A.STURA,E.ORLANDINI JRNL TITL SYNTHESIS AND STRUCTURAL ANALYSIS OF HALOGEN SUBSTITUTED JRNL TITL 2 FIBRIL FORMATION INHIBITORS OF HUMAN TRANSTHYRETIN (TTR). JRNL REF J ENZYME INHIB MED CHEM V. 31 40 2016 JRNL REFN ESSN 1475-6374 JRNL PMID 27067161 JRNL DOI 10.3109/14756366.2016.1167048 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.70 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 38397 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1920 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.7087 - 3.6143 0.97 2737 144 0.1808 0.1975 REMARK 3 2 3.6143 - 2.8691 1.00 2666 140 0.1674 0.1626 REMARK 3 3 2.8691 - 2.5065 1.00 2649 140 0.1809 0.2039 REMARK 3 4 2.5065 - 2.2773 1.00 2626 138 0.1841 0.2105 REMARK 3 5 2.2773 - 2.1141 1.00 2616 138 0.1772 0.1916 REMARK 3 6 2.1141 - 1.9895 1.00 2590 136 0.1846 0.1893 REMARK 3 7 1.9895 - 1.8899 1.00 2591 137 0.1963 0.2127 REMARK 3 8 1.8899 - 1.8076 1.00 2607 137 0.2095 0.2238 REMARK 3 9 1.8076 - 1.7380 1.00 2570 135 0.2358 0.2653 REMARK 3 10 1.7380 - 1.6780 0.99 2590 136 0.2529 0.3331 REMARK 3 11 1.6780 - 1.6256 1.00 2604 138 0.2730 0.3018 REMARK 3 12 1.6256 - 1.5791 0.99 2557 134 0.2824 0.3000 REMARK 3 13 1.5791 - 1.5375 0.99 2557 135 0.3105 0.3381 REMARK 3 14 1.5375 - 1.5000 0.98 2517 132 0.3367 0.3165 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.017 2129 REMARK 3 ANGLE : 2.022 2938 REMARK 3 CHIRALITY : 0.117 314 REMARK 3 PLANARITY : 0.014 395 REMARK 3 DIHEDRAL : 18.170 780 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5E4O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000214347. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5-6 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9801 REMARK 200 MONOCHROMATOR : CRYOGENICALLY COOLED CHANNEL-CUT REMARK 200 SI[111] MONOCHROMATOR REMARK 200 OPTICS : A CONVEX PREFOCUSSING MIRROR AND REMARK 200 A KIRKPATRICK-BAEZ PAIR OF REMARK 200 FOCUSSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38419 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 43.467 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.930 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : 15.1900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.85 REMARK 200 R MERGE FOR SHELL (I) : 1.20000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.630 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC RIGID BODY REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: LONG JAGGED CRYSTAL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 5MG/ML TTR AND 1 MILLI-M REMARK 280 INHIBITOR. PRECIPITANT: 25% PEG4K, 0.2M IMIDAZOLE MALATE, PH REMARK 280 6.0. SLOW DESSICATION OVER 18 MONTHS, REHYDRATED OVER 4 HOURS. REMARK 280 CRYOPROTECTANT: 40% CRYOSOL SM1, 25% MPEG 5K, 0.1M (NA ACETATE, REMARK 280 ADA, BICINE, 80% PH 4.0/20% PH 9.0), VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 21.73500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.46500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.73500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.46500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 C06 L57 A 201 LIES ON A SPECIAL POSITION. REMARK 375 C03 L57 A 201 LIES ON A SPECIAL POSITION. REMARK 375 CL1 L57 B 201 LIES ON A SPECIAL POSITION. REMARK 375 C06 L57 B 201 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 301 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 126 REMARK 465 PRO B 125 REMARK 465 LYS B 126 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 18 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 39 -0.10 85.38 REMARK 500 ASP B 39 12.36 83.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L57 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L57 B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5E23 RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A RELATED INHIBITOR. REMARK 900 RELATED ID: 5E4A RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A RELATED INHIBITOR. REMARK 900 RELATED ID: 4TQH RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A RELATED INHIBITOR. REMARK 900 RELATED ID: 4TQP RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A RELATED INHIBITOR. REMARK 900 RELATED ID: 4TQ8 RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A RELATED INHIBITOR. REMARK 900 RELATED ID: 4TQI RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH A RELATED INHIBITOR. DBREF 5E4O A 10 126 UNP P02766 TTHY_HUMAN 30 146 DBREF 5E4O B 10 126 UNP P02766 TTHY_HUMAN 30 146 SEQRES 1 A 117 CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL ARG GLY SEQRES 2 A 117 SER PRO ALA ILE ASN VAL ALA VAL HIS VAL PHE ARG LYS SEQRES 3 A 117 ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER GLY LYS SEQRES 4 A 117 THR SER GLU SER GLY GLU LEU HIS GLY LEU THR THR GLU SEQRES 5 A 117 GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU ILE ASP SEQRES 6 A 117 THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER PRO PHE SEQRES 7 A 117 HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN ASP SER SEQRES 8 A 117 GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SER PRO SEQRES 9 A 117 TYR SER TYR SER THR THR ALA VAL VAL THR ASN PRO LYS SEQRES 1 B 117 CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL ARG GLY SEQRES 2 B 117 SER PRO ALA ILE ASN VAL ALA VAL HIS VAL PHE ARG LYS SEQRES 3 B 117 ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER GLY LYS SEQRES 4 B 117 THR SER GLU SER GLY GLU LEU HIS GLY LEU THR THR GLU SEQRES 5 B 117 GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU ILE ASP SEQRES 6 B 117 THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER PRO PHE SEQRES 7 B 117 HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN ASP SER SEQRES 8 B 117 GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SER PRO SEQRES 9 B 117 TYR SER TYR SER THR THR ALA VAL VAL THR ASN PRO LYS HET L57 A 201 21 HET L57 B 201 21 HETNAM L57 ({(Z)-[(3,4-DICHLOROPHENYL)(PHENYL) HETNAM 2 L57 METHYLIDENE]AMINO}OXY)ACETIC ACID FORMUL 3 L57 2(C15 H11 CL2 N O3) FORMUL 5 HOH *158(H2 O) HELIX 1 AA1 ASP A 74 LEU A 82 1 9 HELIX 2 AA2 ASP B 74 LEU B 82 1 9 SHEET 1 AA1 8 SER A 23 PRO A 24 0 SHEET 2 AA1 8 LEU A 12 ASP A 18 -1 N ASP A 18 O SER A 23 SHEET 3 AA1 8 ARG A 104 SER A 112 1 O LEU A 111 N LEU A 17 SHEET 4 AA1 8 SER A 115 THR A 123 -1 O VAL A 121 N THR A 106 SHEET 5 AA1 8 SER B 115 THR B 123 -1 O THR B 118 N TYR A 116 SHEET 6 AA1 8 ARG B 104 SER B 112 -1 N ARG B 104 O THR B 123 SHEET 7 AA1 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA1 8 SER B 23 PRO B 24 -1 O SER B 23 N ASP B 18 SHEET 1 AA2 8 GLU A 54 LEU A 55 0 SHEET 2 AA2 8 LEU A 12 ASP A 18 -1 N VAL A 14 O LEU A 55 SHEET 3 AA2 8 ARG A 104 SER A 112 1 O LEU A 111 N LEU A 17 SHEET 4 AA2 8 SER A 115 THR A 123 -1 O VAL A 121 N THR A 106 SHEET 5 AA2 8 SER B 115 THR B 123 -1 O THR B 118 N TYR A 116 SHEET 6 AA2 8 ARG B 104 SER B 112 -1 N ARG B 104 O THR B 123 SHEET 7 AA2 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA2 8 GLU B 54 LEU B 55 -1 O LEU B 55 N VAL B 14 SHEET 1 AA3 8 TRP A 41 LYS A 48 0 SHEET 2 AA3 8 ALA A 29 LYS A 35 -1 N VAL A 32 O ALA A 45 SHEET 3 AA3 8 GLY A 67 ILE A 73 -1 O GLU A 72 N HIS A 31 SHEET 4 AA3 8 HIS A 88 ALA A 97 -1 O ALA A 91 N ILE A 73 SHEET 5 AA3 8 HIS B 88 ALA B 97 -1 O GLU B 89 N VAL A 94 SHEET 6 AA3 8 GLY B 67 ILE B 73 -1 N GLY B 67 O ALA B 97 SHEET 7 AA3 8 ALA B 29 LYS B 35 -1 N HIS B 31 O GLU B 72 SHEET 8 AA3 8 TRP B 41 LYS B 48 -1 O ALA B 45 N VAL B 32 SITE 1 AC1 9 LYS A 15 LEU A 17 THR A 106 ALA A 108 SITE 2 AC1 9 LEU A 110 SER A 117 THR A 119 VAL A 121 SITE 3 AC1 9 HOH A 319 SITE 1 AC2 6 LYS B 15 LEU B 17 ALA B 108 LEU B 110 SITE 2 AC2 6 SER B 117 VAL B 121 CRYST1 43.470 84.930 63.890 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023004 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011774 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015652 0.00000